Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Idiopathic Pulmonary Fibrosis Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of idiopathic pulmonary fibrosis
5.1.1.2. Advancements in the medical and diagnostic technology
5.1.2. Restraints
5.1.2.1. High cost of therapies and treatments
5.1.3. Opportunities
5.1.3.1. Innovations in the precision medicine and development of targeted therapies
5.1.3.2. Designation of idiopathic pulmonary fibrosis as orphan disease and incentives to develop IPF drugs
5.1.4. Challenges
5.1.4.1. Concerns associated with side-effects and potential risk of IPF treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Idiopathic Pulmonary Fibrosis Market, by Drug Type
6.1. Introduction
6.2. Nintedanib
6.3. Pirfenidone

7. Idiopathic Pulmonary Fibrosis Market, by Distribution Channel
7.1. Introduction
7.2. Offline
7.3. Online

8. Idiopathic Pulmonary Fibrosis Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Home Care Facilities
8.4. Hospitals & Clinics

9. Americas Idiopathic Pulmonary Fibrosis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Idiopathic Pulmonary Fibrosis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Idiopathic Pulmonary Fibrosis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Algernon Pharmaceuticals Inc.
13.1.2. Alkem Laboratories Ltd.
13.1.3. AstraZeneca PLC
13.1.4. Avalyn Pharma Inc.
13.1.5. Biogen, Inc.
13.1.6. Boehringer Ingelheim International GmbH
13.1.7. Bristol Myers Squibb
13.1.8. Camber Pharmaceuticals, Inc. by Hetero Labs Limited
13.1.9. Chemo Healthcare Pvt. Ltd.
13.1.10. Cipla Limited
13.1.11. Dr Reddy’s Laboratories Ltd.
13.1.12. FibroGen, Inc.
13.1.13. Galapagos NV
13.1.14. Glenmark Pharmaceuticals Ltd.
13.1.15. GNI Group Ltd.
13.1.16. Horizon Therapeutics PLC by Amgen Inc.
13.1.17. Lupin Ltd.
13.1.18. MediciNova, Inc.
13.1.19. Merck & Co.
13.1.20. Mission Therapeutics
13.1.21. MSN Laboratories Private Limited
13.1.22. Sandoz International GmbH
13.1.23. Sanify Healthcare Private Limited
13.1.24. Shionogi & Co., Ltd.
13.1.25. Teva Pharmaceuticals, Inc.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. IDIOPATHIC PULMONARY FIBROSIS MARKET RESEARCH PROCESS
FIGURE 2. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, 2023 VS 2030
FIGURE 3. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IDIOPATHIC PULMONARY FIBROSIS MARKET DYNAMICS
FIGURE 7. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 8. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 10. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. IDIOPATHIC PULMONARY FIBROSIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. IDIOPATHIC PULMONARY FIBROSIS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IDIOPATHIC PULMONARY FIBROSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 6. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY NINTEDANIB, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY PIRFENIDONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 9. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 12. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. CANADA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 26. CANADA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. CANADA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. MEXICO IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. MEXICO IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CHINA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 43. CHINA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CHINA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. INDIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. INDIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. INDIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. JAPAN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. JAPAN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. THAILAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. THAILAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. DENMARK IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 80. DENMARK IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. DENMARK IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EGYPT IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EGYPT IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. FINLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. FINLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. FRANCE IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FRANCE IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. GERMANY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. GERMANY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ITALY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. ITALY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ITALY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NORWAY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. NORWAY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. POLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 110. POLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. POLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. QATAR IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 113. QATAR IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. QATAR IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SPAIN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SPAIN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. TURKEY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. TURKEY IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. IDIOPATHIC PULMONARY FIBROSIS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 143. IDIOPATHIC PULMONARY FIBROSIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 144. IDIOPATHIC PULMONARY FIBROSIS MARKET LICENSE & PRICING